Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SLC7A7 |
| Upstream (Parents) |
|---|
| (<<) IFI30 → SLC7A7 |
| (<<) TFEC → SLC7A7 |
| (<<) CD53 → SLC7A7 |
| Downstream (Children) |
|---|
| SLC7A7 → CD22 (>>) |
| SLC7A7 → HIGD1B (>>) |
| SLC7A7 → ALK (>>) |
| SLC7A7 → MIP (>>) |
| SLC7A7 → FAM169A (>>) |
| SLC7A7 → KIR2DS1 (>>) |
